Stay updated on NasoVAX in Early COVID-19 Clinical Trial
Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.

Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new site revision label, v3.5.4, replacing the previous v3.5.3. This indicates a back-end/UI update with no changes to the study content or listed information.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision/version identifier was updated from v3.5.2 to v3.5.3, signaling a minor platform or content management update. This change does not modify study details or other visible content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2. No substantive changes to study content or documents are indicated.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision history updated to include Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page shows a new Revision: v3.4.2 label and removal of a government funding status notice; neither affects the core study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.